Gradient’s 2024 SOT Annual Meeting Presentations

News & Events

February 2, 2024

Gradient is presenting at the 2024 Annual Meeting of the Society of Toxicology, taking place March 10-14, 2024, in Salt Lake City, Utah. See presentation details below, and click the links to view poster abstracts.

Gradient’s 2024 SOT Meeting Presentations:

“Considerations for Identification Confidence in Chemical Characterization and Risk Assessments”
Isaac Mohar, Joshua Young (US FDA), Eric Sussman (MCRA)
Exhibitor-Hosted Session
Room 155 C
3/13/24 @ 3:00 pm-4:00 pm

P484: Application of a 3D QSAR Approach for the Re-evaluation of Organophosphorus Compounds for Cohort of Concern Identification
Alex Gauthier, Thomas Dugan, Hayley Gadol
Session: Medical Devices
3/11/24 @ 9:15 am-11:15 am

P324: Deriving an Allowable Exposure Limit for Isobornyl Acrylate for Skin Sensitization in Skin-Contacting Consumer Products
Seth Larch, Rebecca Ticknor, Isaac Mohar, Tom Lewandowski
Session: Skin Sensitization
3/11/24 @ 9:15 am-11:15 am

P489: Modifications to Toxtree’s Revised Cramer Module in the Context of Cramer Classification Predictions for Medical Device Extractables
Pranav Mashankar, Brigitte Cronin, Rachel Chang, Joel Cohen
Session: Medical Devices
3/11/24 @ 9:15 am-11:15 am

P482: What Is a More Conservative Approach for Risk Assessment? Comparing Materials Characterization Data with an Extractables Profile for a Permanent Orthopedic Implant
Cassandra Meakin, Catalina Restrepo, Stephanie Kearing, Lindsey Borton
Session: Medical Devices
3/11/24 @ 9:15 am-11:15 am

P483: Derivation of Fit-for-Purpose Non-Cancer Duration-Based TTC Values for Medical Device Constituents
Taylor Builee (Taylor Builee LLC), Sherry Parker (SParker Toxicology and Consulting), Bindu Prabhakar (WuXi AppTec), Frances Hsia (Boston Scientific), Alessia Stornetta (Boston Scientific), Stephen Bond, Michael Peterson, Valériane Levelut (NAMSA)
Session: Medical Devices
3/11/24 @ 9:15 am-11:15 am

P172: Considerations for Deriving a Safe Intake of Propylene Glycol
Charlotte Marsh, Steven Boomhower, Ari Lewis
Session: Safety Assessment: Non-pharmaceutical
3/11/24 @ 11:45 am-1:45 pm

P156: Evaluating the Potential for Reproductive Effects from Intermittent Lead Exposures Using Blood Lead Modeling Under Proposition 65
Steven Boomhower, Jiayang Chien, Rosemary Mattuck, Barbara Beck
Session: Risk Assessment I
3/11/24 @ 2:15 pm-4:15 pm

P375: Critical Analysis of Sperm Parameter Data Used as the Basis for a Tolerable Daily Intake for Bisphenol A
Mary Hixon, Robyn Prueitt, Julie Goodman
Session: Reproductive Toxicology I
3/12/24 @ 11:45 am-1:45 pm

P117: Protecting Against Adverse Reproductive and Gestational Outcomes from Workplace Exposures: Screening Assessments for Developmental and Reproductive Toxicity
Nicole Olgun, Mary Hixon, David Dodge, Tom Lewandowski
Session: Risk Assessment II
3/12/24 @ 11:45 am-1:45 pm

P156: Critical Evaluation of Immunotoxicity Data Used as the Basis for a Tolerable Daily Intake for Bisphenol A
Robyn Prueitt, Mary Hixon, Julie Goodman
Session: Risk Assessment III
3/12/24 @ 2:15 pm-4:15 pm

“#1212: Looking into the Future: How to Evaluate Safety of New and Unique Consumer Electronics”
Tom Lewandowski
Informational Session: From My Cosmetics to Smart Watch, Toxicology Touches It All!
3/12/24 @ 4:45 pm – 6:05 pm, Grand Ballroom J

P414: Applying EEDmax Approach from ISO 10993-17:2023 to Risk Assessment of DEHP
Colleen Clarke, Perry Piatos, Seth Larch, Rachel Chang
Session: Regulation/Policy
3/13/24 @ 2:15 pm-4:15 pm